BioCryst Pharmaceuticals, Inc.
- Targets
- 1
- Filings
- 3
- Median premium
- 10%
- First filing
- Oct 14, 2025
- Latest filing
- Jan 23, 2026
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Astria Therapeutics, Inc. | — | — | 3 | Jan 23, 2026 |
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| Astria Therapeutics, Inc. | — | — | 3 | Jan 23, 2026 |